SLE patients have higher serum S100A8/A9 levels compared with healthy controls, even when their disease is clinically inactive, and serum S100A8/A9 concentrations have been correlated with disease activity and decrease after immunosuppressive treatment [13–17]. Here, S100A8 is linked to systemic lupus erythematosus.